Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.37 |
| ▸ | TERT | O14746 | 5/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | PIN4 | Q9Y237 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.30 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.30 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.30 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13010687 | 0.94 | CYP1B1 (0.33) | CYP1B1TERTTDP1PIN1PIN4 | |
| SCHEMBL13754701 | 0.93 | TERT (0.34) | CYP1B1TERTTDP1 | |
| SCHEMBL3723988 | 0.89 | CYP1B1 (0.35) | CYP1B1TERTTDP1PIN1PIN4 | |
| SCHEMBL3768159 | 0.89 | TERT (0.35) | CYP1B1TERTTDP1PIN1PIN4 | |
| SCHEMBL44947 | 0.87 | CYP1B1 (0.38) | CYP1B1TERTPIN1PIN4STAT3 | |
| SCHEMBL10819507 | 0.87 | CYP1B1 (0.34) | CYP1B1TERTTDP1PIN1PIN4 | |
| SCHEMBL1793691 | 0.87 | CYP1B1 (0.34) | CYP1B1TERTTDP1PIN1PIN4 | |
| SCHEMBL3773226 | 0.86 | SHMT2 (0.34) | CYP1B1TERTTDP1STAT3HIF1A | |
| SCHEMBL19957599 | 0.86 | TSHR (0.31) | — | |
| SCHEMBL12869446 | 0.85 | TERT (0.36) | CYP1B1TERTSTAT3HIF1AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2240970-B1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2018-03-14 | — | — | EP | disclosed |
| EP-2240970-B1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2018-03-14 | — | — | EP | disclosed |
| US-8404844-B2 | Perylene semiconductors and methods of preparation and use thereof | BASF SE (DE) | 2013-03-26 | — | — | US | disclosed |
| US-8404844-B2 | Perylene semiconductors and methods of preparation and use thereof | BASF SE (DE) | 2013-03-26 | — | — | US | disclosed |
| US-20100319778-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2010-12-23 | — | — | US | disclosed |
| WO-2009098252-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100319778-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | CDYL, PNN, CPNE4 | CYP1B1 1024/4885TERT 1226/4885TDP1 1957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.